Difficulty: Medium
Average Score: 85%
Practice
NDM-I stands for New Delhi metallo-betalactamase, an enzyme produced by bacteria like E.coli and Klebsiella pneumonia that confers antibiotic resistance to a number of antibiotics. Which of the following antibiotics is not affected by this enzyme?
Correct answer
B
Rationale
In answering this question, it is crucial to understand the mechanism of action of NDM-1, an enzyme that confers antibiotic resistance. NDM-1 primarily targets beta-lactam antibiotics by hydrolyzing the beta-lactam ring, rendering these antibiotics ineffective.
Option B, Colistin, is not a beta-lactam antibiotic, and therefore, it is not affected by NDM-1. Colistin is a polymyxin antibiotic that acts on the bacterial cell membrane, making it an effective treatment option against NDM-1 producing bacteria.
Options A, C, and D (Cephalosporin, Carbapenem, and Aminoglycoside) are all beta-lactam antibiotics. Hence, they are susceptible to degradation by the NDM-1 enzyme, leading to antibiotic resistance.
In an educational context, understanding the specific mechanisms of antibiotic resistance, such as the action of enzymes like NDM-1, is vital for healthcare professionals in choosing appropriate antibiotic therapies and combating the rise of multidrug-resistant bacteria. This knowledge is crucial in clinical settings to ensure the effective treatment of bacterial infections and to prevent the spread of antibiotic resistance.
Option B, Colistin, is not a beta-lactam antibiotic, and therefore, it is not affected by NDM-1. Colistin is a polymyxin antibiotic that acts on the bacterial cell membrane, making it an effective treatment option against NDM-1 producing bacteria.
Options A, C, and D (Cephalosporin, Carbapenem, and Aminoglycoside) are all beta-lactam antibiotics. Hence, they are susceptible to degradation by the NDM-1 enzyme, leading to antibiotic resistance.
In an educational context, understanding the specific mechanisms of antibiotic resistance, such as the action of enzymes like NDM-1, is vital for healthcare professionals in choosing appropriate antibiotic therapies and combating the rise of multidrug-resistant bacteria. This knowledge is crucial in clinical settings to ensure the effective treatment of bacterial infections and to prevent the spread of antibiotic resistance.